All In MedTech

FDA Clearance Tracker · P980031-S013

INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 9, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 9, 2024

Approved

Time to decision

343 days

Received Oct 2, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P980031-S013
Device name
INTACS PRESCRIPTION INSERTS/INTACS CORNEAL IMPLANTS
Applicant location
Lombard, IL
Received
Oct 2, 2023
Decided
Sep 9, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P980031

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LQE

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located at AJL Ophthalmic, S.A., Ferdinand Zeppelin 1, Parque Tecnologico Alava, 01510 Minano, Araba, Spain, for manufacturing segment components, inspection, cleaning and primary packaging and sterilization of INTACS Corneal Implants

Source documents

Other decisions for Addition Technology

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.